Skip to main content

Day: March 30, 2026

Rocket Lab Receives Regulatory Approval to Acquire Mynaric

By bringing industry-leading satellite laser communication technology in-house Rocket Lab will strengthen its capability to serve the national security needs of multiple sovereign nations and commercial customers globally LONG BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has received regulatory approval to acquire Mynaric AG (“Mynaric”), a leading provider of laser optical communications terminals for air, space, and mobile applications. The transaction was reviewed and approved by Germany’s Federal Ministry for Economic Affairs and Energy and as a result, Rocket Lab expects the transaction to close in April. “Receiving regulatory approval is an important milestone on the path to acquiring...

Continue reading

Ruanyun Edai Technology Inc. Announces 1H 2026 Unaudited Interim Financial Results

NANCHANG, China, March 30, 2026 (GLOBE NEWSWIRE) — Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“Ruanyun” or the “Company”), an innovative artificial intelligence (“AI”) driven education technology company focused on developing and delivering AI-enabled digital education platforms, including intelligent learning tools, assessment platforms, and adaptive learning systems, today announced its unaudited interim financial results for the six months ended September 30, 2025. 1H 2026 (Six Months Ended September 30, 2025) Unaudited Interim Financial HighlightsOur revenue was $366,256 for the six months ended September 30, 2025, compared with $4,109,689 for the six months ended September 30, 2024, representing a decrease of 91.1%. Gross margin was 26.2% for the six months ended September 30, 2025, compared with 42.1% for the six months...

Continue reading

Innventure Reports Fourth Quarter and Full Year 2025 Results

Commercial inflection with >$50 million in bookings in early 2026 Operating companies advancing independent capital formation, materially reducing reliance on Innventure’s balance sheet Consolidated G&A declined 61% in 4Q25 compared to 4Q24, reflecting sustained cost discipline since the public listing ORLANDO, Fla., March 30, 2026 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced financial results for the quarter and year ended December 31, 2025. “The fourth quarter capped a successful 2025 for Innventure. More importantly, the early months of 2026 demonstrate Innventure is at a true commercial inflection point. Our operating companies are executing simultaneously, converting demand into bookings, raising capital independently, and materially reducing the capital...

Continue reading

Progress Software Reports Fiscal First Quarter 2026

BURLINGTON, Mass., March 30, 2026 (GLOBE NEWSWIRE) — Progress Software (Nasdaq: PRGS), a member of the Russell 2000 Index, today announced its financial results for the fiscal first quarter 2026, which ended on February 28, 2026. Progress is the trusted provider of AI-powered digital experience and infrastructure software. The company’s earnings release and a supplemental slide presentation can be accessed via the Investor Events & Presentations link on the Progress Investor Relations webpage. Progress will host a conference call today at 5:00 p.m. ET to discuss its results and outlook. Conference Call DetailsA live webcast of the call will be available using this link. To access the conference call by phone, please use this link to retrieve dial-in details. To avoid delays, we encourage participants to dial in 15 minutes...

Continue reading

TFI International to Release 2026 First Quarter Results

MONTREAL, March 30, 2026 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will release its financial results for the first quarter ended March 31, 2026 via news release on Monday, April 27, 2026 after market close. The company will host a webcast with Alain Bédard, Chairman, President and Chief Executive Officer, and David Saperstein, Chief Financial Officer, on Monday, April 27, 2026 at 5:00 PM Eastern Time, to discuss results. Webcast Details:Date: Monday, April 27, 2026 Time: 5:00 PM Eastern Time Live webcast & replay: Presentations & Reports within the Investors section of the Company website. Alternatively for the live webcast visit webcast.ABOUT TFI INTERNATIONAL TFI International Inc. is a North American...

Continue reading

zSpace Reports Fourth Quarter and Full Year 2025 Financial Results

SAN JOSE, Calif., March 30, 2026 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leading provider of augmented and virtual reality (AR/VR) solutions for education, is announcing its financial results for the three and twelve months ended December 31, 2025. “Our fourth quarter results reflect continued progress against our strategic priorities and our focus on controlling what we can control,” said Paul Kellenberger, CEO of zSpace. “In the quarter, software and services comprised 53% of revenue, a 10ppts increase from a year ago, contributing to gross margin expansion of over 840 basis points. This performance was driven by strong customer renewals, deeper adoption of our software offerings and meaningful customer wins across K-12, CTE and workforce pathways. We expanded our platform capabilities with...

Continue reading

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 submitted to FDA in Q1 2026 following Type B meeting; study initiation on track for 1H 2026 First CMC Development and Readiness Program (CDRP) meeting for LX2006 in Q1 2026; aligned with FDA on flexible approach to process validation such as reduced PPQ manufacturing batches Late-breaking oral presentations at the American College of Cardiology (ACC) Annual Meeting demonstrate continued, encouraging efficacy and safety data across LX2006 and LX2020 programs Established research collaboration with Johnson & Johnson to explore targeted cardiac delivery of AAV gene therapy using novel, localized routes of administration Strengthened leadership team with addition of new Chief Medical Officer and senior appointments bolstering cardiac expertise Cash, cash equivalents...

Continue reading

Beeline Reports 127% Revenue Growth and Improved Loan Economics

Revenue growth expected to accelerate in 2026 Management to host conference call today at 5 p.m. ET to review results and discuss outlook PROVIDENCE, R.I., March 30, 2026 (GLOBE NEWSWIRE) — via IBN — Beeline Holdings, Inc. (Nasdaq: BLNE), the emerging digital mortgage lender and fractional equity platform, today announces financial results for the fourth quarter ended December 31, 2025.  Q4 2025 Financial Highlights Net revenue of $2.5 million, up 127% year-over-year and 8.3% sequentially  Q4 2025 origination volume of $84.7 million, up 44% year-over-yearOperating expenses increased, primarily reflecting $4.2 million in non-cash stock-based compensation; excluding this, operating expenses increased 19% on 127% revenue growth 1Launched BeelineEquity platform and closed initial transactions recorded on the Blockchain...

Continue reading

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

– Announced positive initial comparative analytical results, confirming identical amino-acid sequencing and highly similar functional characteristics to BOTOX® –  – Reported positive FDA BPD Type 2a meeting, with FDA feedback providing a clear framework for advancing the comparative analytical plan for ABP-450 biosimilar program – – Strengthened balance sheet through $6 million PIPE financing and Daewoong note exchange, reducing outstanding debt by more than 90% – – Appointed John Bencich as Chief Financial Officer, adding significant capital markets and strategic leadership experience – IRVINE, Calif., March 30, 2026 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX® (onabotulinumtoxinA) to achieve...

Continue reading

ARKO Petroleum Corp. Reports Fourth Quarter and Full Year 2025 Results

RICHMOND, Va., March 30, 2026 (GLOBE NEWSWIRE) — ARKO Petroleum Corp. (Nasdaq: APC) (“APC” or the “Company”), one of the largest wholesale fuel distributors in the United States, today announced financial results for the fourth quarter and the full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Key Highlights (vs. Year-Ago Period) 1,2Net income for the quarter increased to $8.1 million compared to $7.5 million.  For the year, net income was $32.7 million compared to $40.2 million. Adjusted EBITDA for the quarter increased to $36.9 million compared to $35.4 million.  For the year, Adjusted EBITDA was $143.5 million compared to $139.2 million.   Net cash provided by operating activities for the quarter was $16.4 million compared to $35.1 million.  For the year, net cash provided by operating activities was $79.6...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.